These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20009540)

  • 21. IMMUNOGENICITY AND SAFETY OF QUINVAXEM® (DIPHTHERIA, TETANUS, WHOLE-CELL PERTUSSIS, HEPATITIS B AND HAEMOPHILUS INFLUENZAE TYPE B VACCINE) GIVEN TO VIETNAMESE INFANTS AT 2 TO 4 MONTHS OF AGE.
    Huu TN; Phuong NT; Toan NT; Thang HV
    Southeast Asian J Trop Med Public Health; 2015 Jul; 46(4):753-63. PubMed ID: 26867396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective immunity following vaccination: how is it defined?
    Amanna IJ; Messaoudi I; Slifka MK
    Hum Vaccin; 2008; 4(4):316-9. PubMed ID: 18398296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Varicella susceptibility and vaccination strategies in young adults.
    Jerant AF; DeGaetano JS; Epperly TD; Hannapel AC; Miller DR; Lloyd AJ
    J Am Board Fam Pract; 1998; 11(4):296-306. PubMed ID: 9719352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Active immunization of children with leukemia and other malignancies.
    Ridgway D; Wolff LJ
    Leuk Lymphoma; 1993 Feb; 9(3):177-92. PubMed ID: 8471977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diphtheria, tetanus, and varicella immunity in health care workers in neonatal units.
    dos Santos AM; Ono E; Lobato RT; do Prado SI; Kopelman BI; Cavalcanti CM; Monomi MK; Weckx LY; de Moraes-Pinto MI
    Am J Infect Control; 2008 Mar; 36(2):142-7. PubMed ID: 18313517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the immunogenicity and safety of pentavalent vaccine Quinvaxem in a compact prefilled auto-disabled (cPAD) injection system versus single-dose vials in healthy infants: a phase 3, open-label, randomized, parallel-group, non-inferiority study.
    Capeding MR; Alberto E; Versteilen A; Rauscher M; Bagchi P; Palacios PI
    Int J Infect Dis; 2016 May; 46():71-8. PubMed ID: 26923083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax®) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis®) in adults aged ≥ 40 years not receiving a diphtheria- and tetanus-containing vaccination in the last 20 years.
    Dominicus R; Galtier F; Richard P; Baudin M
    Vaccine; 2014 Jun; 32(31):3942-9. PubMed ID: 24852717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Vaccination in the armies].
    RAMON G
    Bull Int Serv Sante Armees Terre Mer Air; 1953 Mar; 26(3):88-91. PubMed ID: 13066826
    [No Abstract]   [Full Text] [Related]  

  • 29. Medical and nursing students with suboptimal protective immunity against vaccine-preventable diseases.
    Pavlopoulou ID; Daikos GL; Tzivaras A; Bozas E; Kosmidis C; Tsoumakas C; Theodoridou M
    Infect Control Hosp Epidemiol; 2009 Oct; 30(10):1006-11. PubMed ID: 19708792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity, reactogenicity and safety of three-dose primary and booster vaccination with combined diphtheria-tetanus-whole-cell pertussis-hepatitis B-reduced antigen content Haemophilus influenzae type b vaccine in Filipino children.
    Gatchalian SR; Ramakrishnan G; Bock HL; Lefevre I; Jacquet JM
    Hum Vaccin; 2010 Aug; 6(8):664-72. PubMed ID: 20657177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.
    Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L
    Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB).
    Bar-On ES; Goldberg E; Fraser A; Vidal L; Hellmann S; Leibovici L
    Cochrane Database Syst Rev; 2009 Jul; (3):CD005530. PubMed ID: 19588375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Varicella susceptibility and validity of history among U.S. Coast Guard recruits: an outbreak-based study.
    Zimmerman L; Fajardo M; Seward J; Ludwig S; Johnson J; Wharton M
    Mil Med; 2003 May; 168(5):404-7. PubMed ID: 12775178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix(®)): results of two randomized trials.
    Weston WM; Friedland LR; Wu X; Howe B
    Vaccine; 2012 Feb; 30(9):1721-8. PubMed ID: 22212127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Childhood immunization procedures.
    Krugman S; Katz SL
    JAMA; 1977 May; 237(20):2228-30. PubMed ID: 576912
    [No Abstract]   [Full Text] [Related]  

  • 36. Varicella seroepidemiology in United States air force recruits: A retrospective cohort study comparing immunogenicity of varicella vaccination and natural infection.
    Duncan JR; Witkop CT; Webber BJ; Costello AA
    Vaccine; 2017 Apr; 35(18):2351-2357. PubMed ID: 28359621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine.
    Tejedor JC; Moro M; Ruiz-Contreras J; Castro J; Gómez-Campderá JA; Navarro ML; Merino JM; Martín-Ancel A; Roca J; García-del-Río M; Jurado A; Díez-Delgado FJ; Omeñaca F; García-Sicilia J; Boceta R; García-Corbeira P; Jacquet JM; Collard A; Schuerman L;
    Pediatr Infect Dis J; 2006 Aug; 25(8):713-20. PubMed ID: 16874171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Vaccination status of French and European travelers: a study of 9,156 subjects departing from Paris to 12 tropical destinations].
    Prazuck T; Semaille C; Defayolle M; Bargain P; Clerel M; Lafaix C; Santin A; Fisch A
    Rev Epidemiol Sante Publique; 1998 Feb; 46(1):64-7. PubMed ID: 9533236
    [No Abstract]   [Full Text] [Related]  

  • 39. Seroprotection to vaccine-preventable diseases among workers at a Victorian tertiary hospital.
    Andrew EC; Gibney KB; Denholm J; Leder K
    Aust N Z J Public Health; 2016 Jun; 40(3):284-9. PubMed ID: 27027875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines.
    Shinefield H; Black S; Thear M; Coury D; Reisinger K; Rothstein E; Xu J; Hartzel J; Evans B; Digilio L; Schödel F; Brown ML; Kuter B;
    Pediatr Infect Dis J; 2006 Apr; 25(4):287-92. PubMed ID: 16567978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.